Aryoseven is a medication that contains eptacog alfa and is used in the treatment of bleeding disorders such as hemophilia. It can be used to reduce the risk of bleeding or to stop bleeding. Aryoseven should be prescribed by a doctor and used under the supervision of a healthcare professional. The dosage, duration of treatment, and frequency of use of the medication may vary depending on the patient’s condition and needs. If you are looking for more information or recommendations about Aryoseven, it is important to consult a healthcare professional.
What Is Aryoseven Used For?
Aryoseven is used in the treatment of the following conditions:
- Inhibitors in Hemophilia A
- Factor VII Deficiency in Hemophilia A and B
- Surgical procedures
How Is Aryoseven Used?
Before using Aryoseven, it is essential to seek instructions from a healthcare professional or your doctor:
Dosage: The dosage is determined by the doctor based on the severity of the bleeding, body weight, and treatment goals.
Administration Route: Aryoseven is usually administered intravenously.
Treatment Duration: The duration and frequency of Aryoseven use may vary depending on the patient’s needs.
Special Instructions: Your doctor will provide you with specific instructions on how to use Aryoseven.
Side Effects and Monitoring: You will be informed about possible side effects that may occur during the use of Aryoseven.
What Are the Side Effects of Aryoseven?
Some side effects may occur when using Aryoseven:
- Pain or irritation at the injection site
- Headache
- Nausea or vomiting
- Skin reactions
- Thromboembolic events
- Bleeding
- Allergic reactions
Does Aryoseven Interact with Other Medications?
Some possible interactions of Aryoseven include:
- Anticoagulants
- Other Blood Coagulation Factors
When Should Aryoseven Not Be Used?
Aryoseven may not be used or may need to be used with caution in certain situations:
Allergic Reactions: If you have previously experienced an allergic reaction to Aryoseven or similar medications, you may need to avoid using this medication.
Tromboembolic Events: In patients prone to blood clots, the use of Aryoseven may increase the risk of thromboembolic events.
Blood Pressure Problems: If you have high blood pressure or other blood pressure problems, you should discuss this with your doctor before using Aryoseven.
Pregnancy and Breastfeeding: If you are pregnant or breastfeeding, you should discuss the use of Aryoseven with your doctor.
Other Medical Conditions: If you have other medical conditions such as drug allergies, severe liver or kidney problems, these conditions may affect the use of Aryoseven.
Other Medications: If you are using Aryoseven with other medications, you should discuss the potential interactions of these medications with your doctor.
What Precautions Should Be Taken When Using Aryoseven?
There are some important precautions to be taken when using Aryoseven:
Compliance with Doctor’s Instructions: You should always use Aryoseven in accordance with your doctor’s instructions.
Attention to the Injection Site: Aryoseven is usually administered intravenously.
Monitoring for Side Effects: If you notice any side effects or adverse reactions during the use of Aryoseven, you should consult your doctor immediately.
Blood Pressure Control: Regularly monitor your blood pressure as the use of Aryoseven may affect it.
Interaction with Other Medications: If you are using other medications or supplements while using Aryoseven, you should share the possible interactions of these medications with your doctor.
Pregnancy and Breastfeeding: If you are pregnant or breastfeeding, you should discuss the use of Aryoseven with your doctor.
Sharing Medical Conditions: You should fully disclose your medical history and current health condition to your doctor.
Monitoring and Follow-up: During Aryoseven treatment, you should regularly follow up with your doctor.
Availability of Aryoseven in Turkey
Aryoseven is available in Turkey and is covered by the Social Security Institution (SGK) reimbursement. The retail price for 1 vial of Aryoseven IV Injection Solution Powder and Solvent 1.2 mg (60 KIU) + 1 solvent vial packaging is 10,330.68 TL.